LV14884A - 1,4-dihydropyridin-4-yl-piridynium salts as novel ago-allosteric modulators of adenosine a2a receptors - Google Patents

1,4-dihydropyridin-4-yl-piridynium salts as novel ago-allosteric modulators of adenosine a2a receptors

Info

Publication number
LV14884A
LV14884A LVP-13-02A LV130002A LV14884A LV 14884 A LV14884 A LV 14884A LV 130002 A LV130002 A LV 130002A LV 14884 A LV14884 A LV 14884A
Authority
LV
Latvia
Prior art keywords
piridynium
dihydropyridin
adenosine
receptors
salts
Prior art date
Application number
LVP-13-02A
Other languages
Latvian (lv)
Other versions
LV14884B (en
Inventor
Gunārs DUBURS
Jānis Kloviņš
Imanta Brūvere
Ramona PETROVSKA
Ilona Mandrika
Vita Ignatoviča
Egils Bisenieks
Jānis ULDRIĶIS
Jānis Poikāns
Brigita VĪGANTE
Original Assignee
Latvijas Organiskās Sintēzes Institūts
Latvijas Biomedicīnas Pētījumu Un Studiju Centrs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskās Sintēzes Institūts, Latvijas Biomedicīnas Pētījumu Un Studiju Centrs filed Critical Latvijas Organiskās Sintēzes Institūts
Priority to LVP-13-02A priority Critical patent/LV14884B/en
Publication of LV14884A publication Critical patent/LV14884A/en
Publication of LV14884B publication Critical patent/LV14884B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

The present invention pertains to the field of biochemistry and medicine, particularly to derivatives of 1,4-dihydropyridin-4-yl-piridynium salts as modulators of adenosine A2A receptors useable in medicine for prevention of inflammatory processes related pathologies, for treatment of COPD, diabetic ulcers as well as for regulation of arterial pressure.
LVP-13-02A 2013-01-17 2013-01-17 1,4-dihydropyridin-4-yl-piridynium salts as novel ago-allosteric modulators of adenosine a2a receptors LV14884B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LVP-13-02A LV14884B (en) 2013-01-17 2013-01-17 1,4-dihydropyridin-4-yl-piridynium salts as novel ago-allosteric modulators of adenosine a2a receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-13-02A LV14884B (en) 2013-01-17 2013-01-17 1,4-dihydropyridin-4-yl-piridynium salts as novel ago-allosteric modulators of adenosine a2a receptors

Publications (2)

Publication Number Publication Date
LV14884A true LV14884A (en) 2014-07-20
LV14884B LV14884B (en) 2014-10-20

Family

ID=51176766

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-13-02A LV14884B (en) 2013-01-17 2013-01-17 1,4-dihydropyridin-4-yl-piridynium salts as novel ago-allosteric modulators of adenosine a2a receptors

Country Status (1)

Country Link
LV (1) LV14884B (en)

Also Published As

Publication number Publication date
LV14884B (en) 2014-10-20

Similar Documents

Publication Publication Date Title
MX2018015656A (en) Heterocyclic compounds as antibacterials.
MX2015010125A (en) Pyridazinone-amides derivatives.
NZ738525A (en) Cot modulators and methods of use thereof
TR201901886T4 (en) DNA-PK inhibitors.
PH12016501160A1 (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
PH12014502496B1 (en) Bicyclically substituted uracils and the use thereof
NZ738538A (en) 6-amino-quinoline-3-carbonitrils as cot modulators
PH12015502471A1 (en) Purine derivatives as cb2 receptor agonists
IN2014DN06104A (en)
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
GEP20166489B (en) 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
TN2015000120A1 (en) Oxazolidin-2-one-pyrimidine derivatives
PH12016500525A1 (en) Substituted phenylalanine derivatives
CY1121238T1 (en) PANOTHENIC DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
MX2017013137A (en) Chromene derivatives as phoshoinositide 3-kinases inhibitors.
EA201590503A1 (en) ALPHA-1-Microglobulin for use in the treatment of diseases associated with mitochondria
AU2016204389A1 (en) Kinase inhibitors for the treatment of cancer
MX2016006544A (en) Withanolides useful for the treatment of neurodegenerative diseases.
MX363458B (en) Novel tetrazolone derivatives.
MX2015014470A (en) Combretastatin analogs.
UA117567C2 (en) Galactagogue compositions based on phosphatidylserine
EA201691036A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
EA201690914A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
EA201401045A1 (en) CONNECTIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ISCHEMIA-REPERFUSION
MX2016001691A (en) Bag3 receptor binding molecules for use as a medicament.